Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/10/26 16:02 | 7/9/26 | INSM | Health | Drug | Pharmaceutical Preparations | Lewis William | NJ | DO | Chair,CE | 11 | M.d | 11,922 | 79.88 | 0 | 149 | 39 | 535 | D | ||||||||||||||
7/10/26 16:02 | 7/9/26 | INSM | Health | Drug | Pharmaceutical Preparations | Lewis William | NJ | DO | Chair,CE | 11 | S.d | -11,922 | 79.88 | 0 | -149 | 535 | D | |||||||||||||||
7/8/26 16:03 | 7/6/26 | INSM | Health | Drug | Pharmaceutical Preparations | Flammer Martina M.D. | NJ | O | Chief Me | 6 | M.dm | 5,776 | 78.84 | 0 | 73 | 734 | 83 | D | ||||||||||||||
7/8/26 16:03 | 7/6/26 | INSM | Health | Drug | Pharmaceutical Preparations | Flammer Martina M.D. | NJ | O | Chief Me | 6 | S.dm | -5,776 | 78.84 | 0 | -73 | 83 | D | |||||||||||||||
6/24/26 16:11 | 6/22/26 | INSM | Health | Drug | Pharmaceutical Preparations | Smith Michael Alexander | NJ | O | GC | 4 | S | -1,538 | 108.15 | 0 | -14 | 48 | D | |||||||||||||||
6/5/26 16:15 | 6/3/26 | INSM | Health | Drug | Pharmaceutical Preparations | Adsett Roger | NJ | O | COO | 2 | S | -921 | 112.16 | 0 | -8 | 101 | D | |||||||||||||||
6/5/26 16:14 | 6/3/26 | INSM | Health | Drug | Pharmaceutical Preparations | Bonstein Sara | NJ | O | CFO | 2 | S | -1,207 | 113.05 | 0 | -11 | 71 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |